FDA NDC Directory · JSON-LD · Markdown

lisdexamfetamine dimesylate

NDC 0480-9741 · HUMAN PRESCRIPTION DRUG · TABLET, CHEWABLE

Labeler / ManufacturerTeva Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA215415
Dosage form / routeTABLET, CHEWABLE · ORAL
Active ingredientsLISDEXAMFETAMINE DIMESYLATE (40 mg/1)
Marketing started20240916
Package count1

External sources

Source: openFDA. Public-domain (CC0).